Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Sales (2021 - 2026)

HeartSciences filings provide 6 years of Return on Sales readings, the most recent being 9.81% for Q1 2026.

  • On a quarterly basis, Return on Sales fell 516.0% to 9.81% in Q1 2026 year-over-year; TTM through Jan 2026 was 9.81%, a 516.0% decrease, with the full-year FY2025 number at 20.35%, down 1677.0% from a year prior.
  • Return on Sales hit 9.81% in Q1 2026 for HeartSciences, down from 9.73% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.12% in Q1 2024 to a low of 12.28% in Q2 2023.
  • Median Return on Sales over the past 5 years was 4.94% (2022), compared with a mean of 6.36%.
  • Biggest five-year swings in Return on Sales: tumbled -733bps in 2023 and later surged 870bps in 2024.
  • HeartSciences' Return on Sales stood at 6.62% in 2022, then surged by 32bps to 4.48% in 2023, then grew by 20bps to 3.58% in 2024, then crashed by -172bps to 9.73% in 2025, then fell by -1bps to 9.81% in 2026.
  • The last three reported values for Return on Sales were 9.81% (Q1 2026), 9.73% (Q4 2025), and 10.83% (Q3 2025) per Business Quant data.